<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05065006061405</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>MED-Indexing</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MB-IBE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.509Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061412</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova E</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SBEM-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.489Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061429</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova S</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SP1A-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.467Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061436</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova Go</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SSGA-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.450Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061443</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova F</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FUSV-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.437Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061450</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova D</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GEDRT-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.426Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061467</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova P</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PICT-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.417Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061474</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova R</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GNG2S-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.407Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061481</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova R</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GNG2H-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.391Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061498</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova R</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GNG17H-01</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.371Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061504</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Vela</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SBV450-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.358Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061511</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Vela</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SBV450-IB</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.343Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061528</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Vela U</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>UIECP-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.319Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061535</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Vela U</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>INET-IB</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.302Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061542</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Libra 1</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>STMR-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.283Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061559</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Libra 1</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>STMRCX-01</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.258Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061566</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Medibord</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CASP-01E</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.238Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061573</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Medibord</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CASP-01B</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.223Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061580</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Medibord</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MB-IBI</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.207Z</lastUpdated>
  </row>
  <row>
    <udiDi>05065006061597</udiDi>
    <basicUdiDi>5065006061MedibordX9</basicUdiDi>
    <tradeName>Nova D</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medibord Limited</manufacturerName>
    <manufacturerSrn>UK-MF-000038315</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PATIENT IMMOBILISERS (in diagnostic or therapeutic procedures)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GEDRT-02</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-22T18:14:43.193Z</lastUpdated>
  </row>
</eudamedExport>